Clinical trial
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia (AML) Using Remote Symptom Monitoring
NCT05974150 is registered in ClinicalTrials.gov with Carevive Systems, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia (AML) Using Remote Symptom Monitoring
- Lead sponsor
- Carevive Systems, Inc.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 19, 2023
- Completion date
- December 31, 2026
- Enrollment
- 25 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
acute myelogenous leukemia, breast cancer, lung cancer, multiple myeloma, ovarian cancer